Clinical validation of a genetic model to estimate the risk of developing choroidal neovascular age-related macular degeneration
暂无分享,去创建一个
A. Bansal | R. Guymer | G. Hageman | S. Lejnine | R. Allikmets | M. DeAngelis | P. Baird | C. Deciu | K. Gehrs | L. Perlee | P. Oeth
[1] Ivana K. Kim,et al. The NEI/NCBI dbGAP database: Genotypes and haplotypes that may specifically predispose to risk of neovascular age-related macular degeneration , 2008, BMC Medical Genetics.
[2] Daniel E. Weeks,et al. Interpretation of Genetic Association Studies: Markers with Replicated Highly Significant Odds Ratios May Be Poor Classifiers , 2009, PLoS genetics.
[3] Aaron Y. Lee,et al. Genome-wide association study of advanced age-related macular degeneration identifies a role of the hepatic lipase gene (LIPC) , 2010, Proceedings of the National Academy of Sciences.
[4] D. Weeks,et al. C2 and CFB Genes in Age-Related Maculopathy and Joint Action with CFH and LOC387715 Genes , 2008, PloS one.
[5] R. Guymer,et al. C-reactive protein levels and complement factor H polymorphism interaction in age-related macular degeneration and its progression. , 2010, Ophthalmology.
[6] N. Orr,et al. A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration , 2006, Nature Genetics.
[7] E. Souied,et al. [Epidemiology of age related macular degeneration]. , 2009, Journal Francais d'Ophtalmologie.
[8] Eric N Brown,et al. Complement, age-related macular degeneration and a vision of the future. , 2010, Archives of ophthalmology.
[9] B Rosner,et al. Power and Sample Size Estimation for the Wilcoxon Rank Sum Test with Application to Comparisons of C Statistics from Alternative Prediction Models , 2009, Biometrics.
[10] B S Hawkins,et al. Epidemiology of age-related macular degeneration. , 1999, Molecular vision.
[11] M. Daly,et al. Variation near complement factor I is associated with risk of advanced AMD , 2009, European Journal of Human Genetics.
[12] Yun Li,et al. CFH haplotypes without the Y402H coding variant show strong association with susceptibility to age-related macular degeneration , 2006, Nature Genetics.
[13] Tom H. Pringle,et al. The human genome browser at UCSC. , 2002, Genome research.
[14] R. T. Smith,et al. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[15] J. Ott,et al. Complement Factor H Polymorphism in Age-Related Macular Degeneration , 2005, Science.
[16] A. Edwards,et al. Complement Factor H Polymorphism and Age-Related Macular Degeneration , 2005, Science.
[17] S. Russell,et al. Vitronectin is a constituent of ocular drusen and the vitronectin gene is expressed in human retinal pigmented epithelial cells , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[18] M. Dean,et al. Bringing age-related macular degeneration into focus , 2008, Nature Genetics.
[19] J. Haines,et al. C3 R102G polymorphism increases risk of age-related macular degeneration. , 2008, Human molecular genetics.
[20] C. Patterson,et al. Complement Component 3: an assessment of association with AMD and analysis of gene-gene and gene-environment interactions in a Northern Irish cohort , 2010, Molecular vision.
[21] Margaret A. Pericak-Vance,et al. Genetic variants near TIMP3 and high-density lipoprotein–associated loci influence susceptibility to age-related macular degeneration , 2010, Proceedings of the National Academy of Sciences.
[22] S. Hawken,et al. A genetic approach to stratification of risk for age-related macular degeneration. , 2010, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.
[23] Anand Swaroop,et al. Unraveling a multifactorial late-onset disease: from genetic susceptibility to disease mechanisms for age-related macular degeneration. , 2009, Annual review of genomics and human genetics.
[24] A. Negi,et al. Additional evidence to support the role of a common variant near the complement factor I gene in susceptibility to age-related macular degeneration , 2010, European Journal of Human Genetics.
[25] D. Weeks,et al. Susceptibility genes for age-related maculopathy on chromosome 10q26. , 2005, American journal of human genetics.
[26] C. Craft,et al. Visual Arrestin 1 contributes to cone photoreceptor survival and light adaptation. , 2010, Investigative ophthalmology & visual science.
[27] N. Camp,et al. A Variant of the HTRA1 Gene Increases Susceptibility to Age-Related Macular Degeneration , 2006, Science.
[28] Robert F Mullins,et al. A role for local inflammation in the formation of drusen in the aging eye. , 2002, American journal of ophthalmology.
[29] Robert F. Mullins,et al. An Integrated Hypothesis That Considers Drusen as Biomarkers of Immune-Mediated Processes at the RPE-Bruch's Membrane Interface in Aging and Age-Related Macular Degeneration , 2001, Progress in Retinal and Eye Research.
[30] P. Keane,et al. Risk Factors for Age-Related Maculopathy , 2009, Journal of ophthalmology.
[31] J. Gilbert,et al. Complement Factor H Variant Increases the Risk of Age-Related Macular Degeneration , 2005, Science.
[32] R. Klein,et al. The Beaver Dam Eye Study. Retinopathy in adults with newly discovered and previously diagnosed diabetes mellitus. , 1992, Ophthalmology.
[33] Geoffrey J McLachlan,et al. Selection bias in gene extraction on the basis of microarray gene-expression data , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[34] Don H. Anderson,et al. Age‐related macular degeneration—emerging pathogenetic and therapeutic concepts , 2006, Annals of medicine.
[35] Johanna M Seddon,et al. Common variation in three genes, including a noncoding variant in CFH, strongly influences risk of age-related macular degeneration , 2006, Nature Genetics.
[36] Lars G Fritsche,et al. Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk. , 2005, Human molecular genetics.
[37] J. Saaddine,et al. Forecasting age-related macular degeneration through the year 2050: the potential impact of new treatments. , 2009, Archives of ophthalmology.
[38] J. Gilbert,et al. Independent effects of complement factor H Y402H polymorphism and cigarette smoking on risk of age-related macular degeneration. , 2007, Ophthalmology.
[39] Chi Pui Pang,et al. HTRA1 promoter polymorphism in wet age-related macular degeneration. , 2007, Science.
[40] Don H. Anderson,et al. Extended haplotypes in the complement factor H (CFH) and CFH-related (CFHR) family of genes protect against age-related macular degeneration: characterization, ethnic distribution and evolutionary implications. , 2006, Annals of medicine.
[41] S. Russell,et al. Drusen associated with aging and age‐related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[42] I. Deary,et al. Complement C3 variant and the risk of age-related macular degeneration. , 2007, The New England journal of medicine.
[43] M. Leppert,et al. Determination and Assessment of Extended Haplotypes Spanning the Chromosome 1q32 CFH-To-CFHR5 Locus , 2010 .
[44] Ivana K. Kim,et al. Alleles in the HtrA serine peptidase 1 gene alter the risk of neovascular age-related macular degeneration. , 2008, Ophthalmology.
[45] S. Ennis,et al. Support for the involvement of complement factor I in age-related macular degeneration , 2010, European Journal of Human Genetics.
[46] Ivana K. Kim,et al. Cigarette smoking, CFH, APOE, ELOVL4, and risk of neovascular age-related macular degeneration. , 2007, Archives of ophthalmology.
[47] R. T. Smith,et al. Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration , 2006, Nature Genetics.
[48] R. Guymer,et al. Analysis of the Y402H variant of the complement factor H gene in age-related macular degeneration. , 2006, Investigative ophthalmology & visual science.
[49] Don H. Anderson,et al. The pivotal role of the complement system in aging and age-related macular degeneration: Hypothesis re-visited , 2010, Progress in retinal and eye research.
[50] Johanna M Seddon,et al. Prediction model for prevalence and incidence of advanced age-related macular degeneration based on genetic, demographic, and environmental variables. , 2009, Investigative ophthalmology & visual science.
[51] Johanna M Seddon,et al. Variation in complement factor 3 is associated with risk of age-related macular degeneration , 2007, Nature Genetics.
[52] E. DeLong,et al. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. , 1988, Biometrics.
[53] R. Klein,et al. The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study. , 1997, Ophthalmology.
[54] Zachary Roth,et al. The burden of age-related macular degeneration: a value-based medicine analysis. , 2005, Transactions of the American Ophthalmological Society.